Track the Healius Limited stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares trade on AU AU, under the supervision of ASX. Operating in the Health Care sector, Healius Limited has recorded 11 insider filings. Market capitalisation: €283.2m. The latest transaction was reported on 6 July 2026 (Cease Substantial Holding). Among the most active insiders: Unknown Substantial Holder. Every trade is openly available.
Analysts rate Healius Limited Hold (neutral), based on 10 analysts. Average price target: A$0.51.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Healius Limited is an Australian company specializing in health and diagnostic services. It primarily operates on the Australian Securities Exchange (XASX).